Regional blood flow in herniparkinsonism
暂无分享,去创建一个
[1] M. Hoehn,et al. Parkinsonism , 1967, Neurology.
[2] M. Raichle,et al. A Stereotactic Method of Anatomical Localization for Positron Emission Tomography , 1985, Journal of computer assisted tomography.
[3] D E Kuhl,et al. Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method , 1984, Annals of neurology.
[4] R Harrop,et al. Cerebral Glucose Metabolism in Parkinson’s Disease , 1984, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[5] L. Wolfson,et al. Cerebral blood flow and oxygen metabolism measurement with positron emission tomography in Parkinson's disease. , 1984, Monographs in neural sciences.
[6] Y. Agid,et al. Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease , 1983, Brain Research.
[7] M. Raichle,et al. Brain blood flow measured with intravenous H2(15)O. I. Theory and error analysis. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[8] M. Mintun,et al. Brain blood flow measured with intravenous H2(15)O. II. Implementation and validation. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[9] P. Dupui,et al. Cerebral Blood Flow Studied by Xenon-133 Inhalation Technique in Parkinsonism: Loss of Hyperfrontal Pattern , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[10] R. Roth,et al. Pharmacology of mesocortical dopamine neurons. , 1983, Pharmacological reviews.
[11] Y. Agid,et al. Dopamine deficiency in the cerebral cortex in Parkinson disease , 1982, Neurology.
[12] M. Ter-pogossian,et al. PETT VI: A Positron Emission Tomograph Utilizing Cesium Fluoride Scintillation Detectors , 1982, Journal of computer assisted tomography.
[13] Michel M. Ter-Pogossian,et al. Performance Study of PETT VI, a Positron Computed Tomograph with 288 Cesium Fluoride Detectors , 1982, IEEE Transactions on Nuclear Science.
[14] J C Mazziotta,et al. Quantitation in Positron Emission Computed Tomography: 5. Physical–Anatomical Effects , 1981, Journal of computer assisted tomography.
[15] R. C. Collins,et al. Metabolic effects of unilateral lesion of the substantia nigra , 1981, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[16] D. Kingsley. Atlas of the Human Brain and the Orbit for Computed Tomography , 1981 .
[17] C D Marsden,et al. Assessment of extrapyramidal disorders. , 1981, British journal of clinical pharmacology.
[18] Louis Sokoloff,et al. Activity‐dependent Energy Metabolism in Rat Posterior Pituitary Primarily Reflects Sodium Pump Activity , 1980, Journal of neurochemistry.
[19] S. Bentin,et al. Regional cerebral blood flow in patients with Parkinson's disease. , 1979, Archives of neurology.
[20] T. Jones,et al. Regional impairment of cerebral oxidative metabolism in Parkinson's disease. , 1979, Journal of neurology, neurosurgery, and psychiatry.
[21] J. Murphy,et al. Spatial organization of precentral cortex in awake primates. III. Input-output coupling. , 1978, Journal of neurophysiology.
[22] J. Glowinski,et al. Studies on mesocortical dopamine systems. , 1978, Advances in biochemical psychopharmacology.
[23] M E Raichle,et al. Correlation Between Regional Cerebral Blood Flow and Oxidative Metabolism: In Vivo Studies in Man , 1976 .
[24] R. M. Beckstead,et al. Convergent thalamic and mesencephalic projections to the anterior medial cortex in the rat , 1976, The Journal of comparative neurology.
[25] R. Knill-Jones,et al. Controlled trial of amantadine hydrochloride in Parkinson's disease. , 1970, Lancet.
[26] Edgar M. Housepian. Atlas d'anatomie stereotaxique du telencephale. , 1968 .
[27] O. Hornykiewicz. Dopamine (3-hydroxytyramine) and brain function. , 1966, Pharmacological reviews.